Navigation Links
Drug Eluting Nanostructured Coatings Enable Targeted Drug Therapy for Orthopedic Patients

Drug delivery systems have progressed from the teaspoon to time-release capsules to drug-eluting stents .

Nanotechnology promises yet another advance by delivering therapeutic agents at desired rates exactly where needed in the body.

In a paper presented at the NSTI Nanotech 2007 Conference, researchers at the University of California, San Francisco demonstrate how they have created nanotubes from biocompatible metal oxides that can hold therapeutic proteins or drugs and deliver these agents in a highly-controlled manner.

The fabrication strategies developed by the authors is flexible in terms of controlling the diameter and length scales of the tubes. By changing these physical parameters of nanotubes, they could precisely control the dosage and deliver drugs at physiological rates for desired duration of time.

In the case of orthopedic implants with nanotubes on the implant surfaces, drugs such as antibiotics can be loaded in the tubes and released right at the site of implantation. This method, which targets the drug where it is needed, can avoid the side effects due to high dosages normally given to patients. Further, in cases where a very long treatment regimen is needed, such as in growth factor therapy, nanotubes may provide superior performance.

According to Ketul C. Popat, "When a person has an orthopedic implant surgery, they normally will have to take antibiotics and growth factors either orally or by injection. There are several side effects associated with taking drugs this way which can be very painful for the patient.

However, by placing the drugs on to the surface of these implants, we can deliver them right where they are needed and can avoid larger doses and side effects. The nanostructured coating on the implant surface helps the drug to maintain its bioavailability as well as deliver the drugs at physiological rates for a desired duration of time."


'"/>




Page: 1

Related medicine news :

1. Drug-Eluting Stents Ensure Patency Of The Saphenous Vein Grafts
2. Poor Andhra Women Enable Bypass Surgery Paying 50 Paise Each
3. Small Biosensor To Enable Cancer Detection
4. New Technique Enables Better Nursing Of Robin Sequence Infants
5. Bad Enzymes Found To Enable Brain Recovery Following Stroke
6. Decision-Making Enabled By Neurons: Value Assigned To Available Choices.
7. Micro vascular Disease Enabled with a Superior Test, Courtesy: Women’s Heart Progra
8. Glucose Enables Speedy Recovery From Malaria
9. Single Sugar Enables Antibody to Treat Inflammation
10. Cochlear Implants in Both Ears Enables Better Hearing
11. Electronic Nerve Stimulator Enables Walking
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2017)... ... April 30, 2017 , ... TransLiquid Cartoon is a ... X. Editors can pick and choose from a variety of liquid transitions that ... shadows using simple color swabs. Utilize on-screen controls to fully manipulate transitions through ...
(Date:4/29/2017)... Aliso Viejo, CA (PRWEB) , ... April 29, 2017 , ... ... effects. Seamlessly transition from one video to the next without having to set ... bleeding, ripping, and blasting transitions to enhance your video production. , TransDark features dynamic ...
(Date:4/28/2017)... ... 2017 , ... An April 24th article on Yahoo! Beauty discusses the case of ... of a weight loss surgery. The woman, declaring “I will not hate my body anymore!” ... her dramatic weight loss. Dr. Feiz & Associates notes that, while it often refers its ...
(Date:4/28/2017)... ... April 28, 2017 , ... Beginning in 2017, Ridgecrest Herbals will ... begins with the popular ClearLungs Extra Strength formula. To ensure that the effectiveness of ... the following ways:, , Removal of the homeopathic element , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on ... or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology: